Oncology: State-of-the-Art Research in The Netherlands
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 30 June 2025 | Viewed by 114
Special Issue Editor
Interests: cancer cell biology; cancer cell migration and invasion; MMPs (Matrix metalloproteinases) in cancer cell migration/invasion; nuclear envelope; nuclear envelope rupture and lamins in cancer biology; biomechanics of cancer cell migration/invasion; cancer cell-ECM interaction; ECM geometry during cancer cell migration/invasion; tumor cell plasticity during migration/invasion; contractility in cell migration/invasion
Special Issue Information
Dear Colleagues,
We are pleased to announce a Special Issue entitled "Oncology: State-of-the-Art Research in The Netherlands". The Netherlands has emerged as a leading country in the field of cancer research, with a strong commitment from various stakeholders, including academic institutions, healthcare organizations, industries, funding bodies, and patient advocacy groups. The Dutch healthcare system emphasizes inclusivity and ensures that high-quality care is accessible to all.
This Special Issue aims to highlight the cutting-edge research being conducted in oncology in the Netherlands. We invite researchers to submit their work across a wide range of cancer types and stages, spanning from fundamental laboratory investigations to translational and clinical studies. Submissions may include cohort studies, randomized controlled trials, epidemiological studies, and narrative reviews that delve into the historical background and notable contributions of cancer research in the Netherlands.
We encourage authors to present novel findings, innovative approaches, and multidisciplinary collaborations that have the potential to advance our understanding of cancer biology, diagnosis, treatment, and patient care. Topics of interest include but are not limited to the following:
- Molecular mechanisms underlying cancer initiation and progression;
- Novel diagnostic tools and biomarkers for early detection and personalized treatment;
- Targeted therapies, immunotherapies, and emerging treatment modalities;
- Survivorship and quality of life in cancer patients;
- Palliative care and end-of-life considerations;
- Health economics and policy implications in oncology.
By bringing together the latest research findings, this Special Issue aims to foster knowledge exchange, promote collaboration, and inspire future directions in the field of oncology research in the Netherlands. We look forward to receiving your valuable contributions.
Dr. Katarina Wolf
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer research
- oncology
- The Netherlands
- cutting-edge
- translational studies
